MedTech Acquisition Corporation (MTAC)
|52 Week Range||8.43-12.8299|
|1y Target Est||-|
|DCF Unlevered||MTAC DCF ->|
|DCF Levered||MTAC LDCF ->|
|Debt / Equity||47.79%||Neutral|
Upgrades & Downgrades
Latest MTAC news
Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal
19 August 2021
OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acqu...
Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company
13 August 2021
A SPAC led by the founder of Memic Innovative Surgery and several experienced medical device company executives has announced its merger partner. The SPAC Deal: Memic Innovative Surgery announced a S...